BNTC Benitec Biopharma Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 14, 2026
$8.98
· of 52w range
· above low
· to high
$8.9252w low
$16.7652w high
Market Cap (MRQ)
$309M
P/E
-9.2
EPS
$-0.98
Revenue
$0
your badges
52W Range
$9–$17
Analyst Rating
BUY
Price Target
$24
P/E
-9.2
ROE
-25.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
BNTC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.98
Market Cap (MRQ)
$309M
P/E
-9.2
EPS
$-0.98
Revenue
$0
ROE
-25.0%
52W Range
$9–$17
BNTC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| July 26, 2023 | 1-for-17 | Reverse |
| April 15, 2020 | 1-for-1 | Reverse |
| Nov. 18, 2019 | 1-for-10 | Reverse |
| June 16, 2015 | 1-for-4 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02019-06-30 → 2024-06-30
EPS$-0.982021-06-30 → 2026-06-30
Free Cash Flow$-17M2020-06-30 → 2026-06-30
Net margin·2020-06-30 → 2023-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BNTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -9.25Y avg ≈-6.3 | ≈-6.3 | · | · | |
| P/B (MRQ) | 1.75Y avg ≈19.0 | ≈19.0 | 2.2 | Overvalued | |
| Price / Cash Flow | -18.75Y avg ≈-10.4 | ≈-10.4 | · | · | |
| Price / Tangible Book | 1.75Y avg ≈19.0 | ≈19.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BNTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -32.3%5Y avg ≈-133.4% | ≈-133.4% | -43.8% | Top tier | |
| ROE | -25.0%5Y avg ≈-257.8% | ≈-257.8% | -49.5% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BNTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 34.05Y avg ≈20.4 | ≈20.4 | 5.6 | Strong liquidity | |
| Quick Ratio | 33.75Y avg ≈20.1 | ≈20.1 | 4.4 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BNTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jun 1, 2018 | $0.77 | USD | ≈0.12% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
7.3%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2026 | Nov 12, 2026 | $-0.24 | $-0.28 | 14.1% |
| June 30, 2026 | $-0.26 | $-0.28 | 5.6% | |
| March 31, 2026 | May 14, 2026 | $-0.24 | $-0.28 | 14.0% |
| Dec. 31, 2025 | $-0.26 | $-0.23 | -14.1% | |
| Sept. 30, 2025 | $-0.22 | $-0.38 | 41.4% | |
| June 30, 2025 | $-0.42 | $-0.30 | -42.0% | |
| March 31, 2025 | $-0.24 | $-0.35 | 32.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $75.0K | $73.0K | $59.0K | $102.0K | $12M | |
| R&D Expense | $23M | $18M | $16M | $13M | $11M | $7M | $3M | $5M | |
| SG&A Expense | $28M | $23M | $7M | $6M | $7M | $7M | $6M | $5M | |
| Operating Expenses | $51M | $42M | $22M | $19M | $18M | $14M | $8M | $10M | |
| Operating Income | $-51M | $-42M | $-22M | $-19M | $-18M | $-14M | $-8M | $3M | |
| Other Non-op | $-43.0K | $-131.0K | $-204.0K | $-30.0K | $-79.0K | $37.0K | $34.0K | · | |
| Income Tax | $0 | · | · | · | · | · | · | · | |
| Net Income | $-46M | $-38M | $-22M | $-20M | $-18M | $-14M | $-8M | $3M | |
| EPS (Basic) | $-0.98 | $-1.05 | $-1.22 | $-14.12 | $-37.88 | $-3.23 | · | · | |
| EPS (Diluted) | $-0.98 | $-1.05 | $-1.22 | $-14.12 | $-37.88 | $-3.23 | · | · | |
| Shares (Basic) | 46,558,162 | 36,209,271 | 18,364,386 | 1,385,818 | 480,688 | 4,295,416 | · | · | |
| Shares (Diluted) | 46,558,162 | 36,209,271 | 18,364,386 | 1,385,818 | 480,688 | 4,295,416 | · | · | |
| EBITDA | $-51M | $-42M | $-22M | $-19M | $-18M | $-13M | $-8M | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $180M | $98M | $51M | $2M | $4M | $20M | $10M | $16M | |
| Prepaid Expense | $2M | $628.0K | $516.0K | $1M | $741.0K | $799.0K | $949.0K | $375.0K | |
| Other Current Assets | $2M | $628.0K | $516.0K | $1M | $741.0K | $799.0K | $949.0K | $502.0K | |
| Current Assets | $182M | $99M | $52M | $4M | $5M | $21M | $11M | $19M | |
| PP&E (Net) | $178.0K | $131.0K | $179.0K | $87.0K | $222.0K | $375.0K | $374.0K | $470.0K | |
| PP&E (Gross) | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $796.0K | $670.0K | |
| Other Non-current Assets | $12.0K | $28.0K | $62.0K | $97.0K | $135.0K | $185.0K | · | · | |
| Total Assets | $183M | $100M | $52M | $4M | $6M | $21M | $12M | $19M | |
| Current Liabilities | $5M | $2M | $5M | $4M | $3M | $1M | $1M | $3M | |
| Capital Leases | $266.0K | $495.0K | $0 | $284.0K | $559.0K | $0 | $213.0K | · | |
| Total Liabilities | $6M | $2M | $5M | $4M | $3M | $1M | $1M | $3M | |
| Common Stock | $3.0K | $2.0K | $1.0K | $0 | $0 | $1.0K | $0 | $1.0K | |
| Retained Earnings | $-274M | $-228M | $-190M | $-168M | $-148M | $-130M | $-117M | $-109M | |
| AOCI | $-963.0K | $-839.0K | $-892.0K | $-830.0K | $-1M | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $177M | $97M | $47M | $202.0K | $3M | $20M | $10M | $17M | |
| Liabilities + Equity | $183M | $100M | $52M | $4M | $6M | $21M | $12M | $19M | |
| Shares Outstanding | 34,416,834 | 26,250,469 | 10,086,119 | 1,671,485 | 480,688 | 8,171,690 | 1,108,374 | 856,765 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $66.0K | $87.0K | $136.0K | $167.0K | $231.0K | $190.0K | $158.0K | |
| Stock-based Comp | $26M | $17M | $830.0K | $452.0K | $870.0K | $634.0K | $237.0K | $672.0K | |
| Other Non-cash | $3M | $-3M | $1M | $962.0K | $1M | $185.0K | $312.0K | · | |
| Operating Cash Flow | $-17M | $-24M | $-19M | $-18M | $-16M | $-13M | $-8M | $5M | |
| CapEx | $105.0K | $18.0K | $179.0K | $1.0K | $13.0K | $221.0K | $95.0K | $404.0K | |
| Investing Cash Flow | $-105.0K | $-18.0K | $-179.0K | $-1.0K | $-13.0K | $-221.0K | $-94.0K | $-400.0K | |
| Stock Issued | $104M | $30M | · | $18M | · | $26M | $2M | · | |
| Net Stock Activity | $104M | · | · | $18M | · | $26M | $2M | · | |
| Financing Cash Flow | $99M | $70M | $68M | $16M | · | $23M | $2M | · | |
| Net Change in Cash | $82M | $47M | $48M | $-2M | $-16M | $10M | · | · | |
| Free Cash Flow | $-17M | $-24M | $-20M | $-18M | $-16M | $-13M | $-8M | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -25441.3% | -24457.5% | -23044.1% | -8118.6% | · | |
| Net Margin | · | · | · | -26082.7% | -24942.5% | -23528.8% | -8111.8% | · | |
| EBITDA Margin | · | · | · | -25260.0% | -24228.8% | -22652.5% | -7932.3% | · | |
| ROA | -32.3% | -50.0% | -76.8% | -374.9% | -133.1% | -84.2% | -53.7% | · | |
| ROE | -25.0% | -43.8% | -74.1% | -796.0% | -350.1% | -89.7% | -73.3% | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 34.0 | 54.7 | 10.5 | 0.9 | 1.9 | 15.1 | 9.5 | · | |
| Quick Ratio | 33.7 | 54.2 | 10.3 | 0.6 | 1.6 | 14.4 | 8.6 | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.14 | $3.71 | $28.27 | $0.12 | $0.35 | $2.45 | $9.24 | · | |
| Revenue / Share | · | · | $0.00 | $0.05 | $0.01 | · | · | · | |
| Cash Flow / Share | $-0.35 | $-0.65 | $-4.78 | $-13.00 | $-1.95 | · | · | · | |
| Cash / Share | $5.23 | $3.72 | $30.43 | $1.50 | $0.50 | $2.42 | $8.84 | · | |
| EPS (TTM) | $-0.98 | $-1.05 | $-1.22 | $-14.12 | $-37.88 | $-3.23 | · | · |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 2.7% | 23.7% | -42.2% | · | · | |
| Revenue CAGR 3Y | · | · | · | -9.7% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $75.0K | $73.0K | $59.0K | $102.0K | · | |
| Net Income TTM | $-46M | $-38M | $-22M | $-20M | $-18M | $-14M | $-8M | · | |
| Market Cap | $460M | $307M | $12M | $7M | $161M | $590M | $149M | · | |
| P/E | -13.7 | -11.1 | -5.7 | -0.3 | -0.5 | -22.4 | · | · | |
| P/S | · | · | · | 89.2 | 2207.5 | 10006.9 | 1461.2 | · | |
| P/B | 2.6 | 3.2 | 0.2 | 33.1 | 55.9 | 29.5 | 14.6 | · | |
| P / Tangible Book | 2.6 | 3.2 | 0.2 | 33.1 | 55.9 | 29.5 | 14.6 | · | |
| P / Cash Flow | -27.9 | -13.0 | -0.6 | -0.4 | -10.1 | -46.0 | -19.8 | · | |
| P / FCF | · | -13.0 | -0.6 | -0.4 | -10.1 | -45.2 | -19.5 | · | |
| Earnings Yield | -7.3% | -9.0% | -17.4% | -347.5% | -192.1% | -4.5% | · | · |
Income Statement
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $7.0K | $54.0K | $14.0K | $0 | |
| R&D Expense | $8M | $6M | $6M | $3M | $3M | $6M | $5M | $4M | $4M | $3M | $5M | $4M | $3M | $3M | $4M | $3M | |
| SG&A Expense | $7M | $7M | $8M | $6M | $7M | $9M | $5M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | |
| Operating Expenses | $14M | $14M | $13M | $10M | $10M | $15M | $11M | $6M | $6M | $4M | $7M | $6M | $5M | $4M | $6M | $5M | |
| Operating Income | $-14M | $-14M | $-13M | $-10M | $-10M | $-15M | $-11M | $-6M | $-6M | $-4M | $-7M | $-6M | $-5M | $-4M | $-6M | $-5M | |
| Other Non-op | $39.0K | $-17.0K | $19.0K | $-84.0K | $-126.0K | $0 | $-40.0K | $35.0K | $-154.0K | $-16.0K | $-16.0K | $-18.0K | $-80.0K | $0 | $50.0K | $0 | |
| Net Income | $-13M | $-12M | $-12M | $-9M | $-9M | $-15M | $-10M | $-5M | $-5M | $-4M | $-7M | $-6M | $-5M | $-4M | $-5M | $-5M | |
| EPS (Basic) | $-0.26 | $-0.24 | $-0.26 | $-0.22 | $-0.23 | $-0.38 | $-0.26 | $-0.18 | $4.70 | $-0.23 | $-2.64 | $-3.05 | $-0.13 | $-2.67 | $-3.34 | $-7.98 | |
| EPS (Diluted) | $-0.26 | $-0.24 | $-0.26 | $-0.22 | $-0.23 | $-0.38 | $-0.26 | $-0.18 | $4.70 | $-0.23 | $-2.64 | $-3.05 | $-0.13 | $-2.67 | $-3.34 | $-7.98 | |
| Shares (Basic) | · | 49,386,203 | 45,970,516 | 41,521,280 | 41,161,259 | 38,599,453 | 37,254,839 | 27,883,624 | · | 18,281,896 | 2,576,347 | 2,157,065 | · | 1,645,951 | 1,621,280 | 638,572 | |
| Shares (Diluted) | · | 49,386,203 | 45,970,516 | 41,521,280 | 41,161,259 | 38,599,453 | 37,254,839 | 27,883,624 | · | 18,281,896 | 2,576,347 | 2,157,065 | · | 1,645,951 | 1,621,280 | 638,572 | |
| EBITDA | · | $-14M | $-13M | $-10M | · | $-10M | $-9M | $-6M | · | $-4M | $-7M | $-6M | · | $-4M | $-6M | $-5M |
Balance Sheet
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $180M | $185M | $189M | $94M | $98M | $104M | $78M | $68M | $51M | $14M | $20M | $26M | $2M | $7M | $11M | $17M | |
| Prepaid Expense | $2M | $1M | $562.0K | $480.0K | $628.0K | $361.0K | $366.0K | $426.0K | $516.0K | $157.0K | $355.0K | $482.0K | $1M | $774.0K | $356.0K | $531.0K | |
| Other Current Assets | $2M | $1M | $562.0K | $480.0K | $628.0K | $361.0K | $366.0K | $426.0K | $516.0K | $157.0K | $355.0K | $482.0K | $1M | $774.0K | $356.0K | $531.0K | |
| Current Assets | $182M | $186M | $190M | $95M | $99M | $104M | $79M | $68M | $52M | $14M | $21M | $26M | $4M | $7M | $11M | $17M | |
| PP&E (Net) | $178.0K | $116.0K | $115.0K | $118.0K | $131.0K | $145.0K | $151.0K | $154.0K | $179.0K | $204.0K | $51.0K | $68.0K | $87.0K | $106.0K | $139.0K | $179.0K | |
| PP&E (Gross) | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $12.0K | $12.0K | $11.0K | $20.0K | $28.0K | $35.0K | $42.0K | $56.0K | $62.0K | $69.0K | $81.0K | $85.0K | $97.0K | $105.0K | $116.0K | $119.0K | |
| Total Assets | $183M | $187M | $191M | $96M | $100M | $105M | $79M | $69M | $52M | $15M | $21M | $27M | $4M | $8M | $12M | $18M | |
| Current Liabilities | $5M | $3M | $3M | $2M | $2M | $7M | $3M | $5M | $5M | $3M | $6M | $5M | $4M | $3M | $2M | $3M | |
| Capital Leases | $266.0K | $394.0K | $519.0K | $403.0K | $495.0K | $613.0K | $0 | $0 | $0 | $62.0K | $137.0K | $211.0K | $284.0K | $354.0K | $422.0K | $491.0K | |
| Total Liabilities | $6M | $4M | $3M | $2M | $2M | $8M | $3M | $5M | $5M | $3M | $6M | $5M | $4M | $4M | $3M | $4M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-274M | $-261M | $-249M | $-237M | $-228M | $-212M | $-203M | $-195M | $-190M | $-185M | $-181M | $-174M | $-168M | $-163M | $-159M | $-153M | |
| AOCI | $-963.0K | $-952.0K | $-883.0K | $-750.0K | $-839.0K | $-716.0K | $-688.0K | $-993.0K | $-892.0K | $-835.0K | $-952.0K | $-780.0K | $-830.0K | $-853.0K | $-898.0K | $-738.0K | |
| Stockholders' Equity | $177M | $183M | $187M | $94M | $97M | $98M | $76M | $64M | $47M | $12M | $15M | $22M | $202.0K | $5M | $9M | $15M | |
| Liabilities + Equity | $183M | $187M | $191M | $96M | $100M | $105M | $79M | $69M | $52M | $15M | $21M | $27M | $4M | $8M | $12M | $18M | |
| Shares Outstanding | 34,416,834 | 34,354,334 | 34,254,907 | 26,250,469 | 26,250,469 | 25,546,288 | 23,451,475 | 17,893,765 | 10,086,119 | 2,724,794 | 2,592,434 | 2,547,434 | 1,671,485 | 27,981,161 | 27,981,161 | 25,809,533 |
Cash Flow
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17.0K | $14.0K | $14.0K | $13.0K | $14.0K | $13.0K | $14.0K | $25.0K | $26.0K | $25.0K | $17.0K | $19.0K | $21.0K | $32.0K | $41.0K | $42.0K | |
| Stock-based Comp | $6M | $8M | $7M | $5M | $6M | $3M | $3M | $435.0K | $454.0K | $192.0K | $93.0K | $91.0K | $127.0K | $71.0K | $-48.0K | $302.0K | |
| Other Non-cash | · | · | · | $421.0K | · | · | · | $13.0K | · | · | · | $1M | · | · | · | $704.0K | |
| Operating Cash Flow | $-5M | $-4M | $-4M | $-3M | $-8M | $-3M | $-8M | $-5M | $-3M | $-6M | $-5M | $-5M | $-4M | $-4M | $-6M | $-4M | |
| CapEx | $79.0K | $15.0K | · | · | $0 | $6.0K | · | · | $0 | · | · | · | $1.0K | · | · | · | |
| Investing Cash Flow | $-79.0K | $-15.0K | $-11.0K | $0 | $0 | $-6.0K | $-12.0K | $0 | $0 | $-179.0K | $0 | $0 | · | · | $0 | $0 | |
| Stock Issued | $0 | $0 | · | · | $1.0K | $30M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $241.0K | $506.0K | $98M | $0 | $3M | $28M | $18M | $22M | $40M | $0 | $39.0K | $28M | $0 | $0 | $0 | $16M | |
| Net Change in Cash | $-5M | $-4M | $94M | $-3M | $-6M | $25M | $10M | $17M | $37M | $-6M | $-5M | $23M | $-4M | $-4M | $-6M | $12M |
Profitability
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -8038.9% | -40071.4% | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -8142.6% | -38650.0% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -7979.6% | -39778.6% | · | |
| ROA | · | -8.2% | -8.8% | -10.9% | · | -15.6% | -14.6% | -10.6% | · | -36.9% | -40.9% | -26.4% | · | -48.1% | -41.8% | -28.3% | |
| ROE | · | -8.5% | -9.0% | -11.4% | · | -17.2% | -16.1% | -11.7% | · | -52.8% | -55.6% | -32.2% | · | -71.9% | -54.6% | -33.9% |
Liquidity & Solvency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 56.8 | 67.7 | 47.0 | · | 14.8 | 25.5 | 15.0 | · | 4.2 | 3.6 | 5.8 | · | 2.3 | 4.4 | 5.7 | |
| Quick Ratio | · | 56.4 | 67.4 | 46.7 | · | 14.7 | 25.3 | 14.9 | · | 4.1 | 3.5 | 5.7 | · | 2.1 | 4.2 | 5.5 |
Efficiency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Per Share
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $5.34 | $5.47 | $3.57 | · | $3.82 | $3.24 | $3.59 | · | $4.22 | $5.97 | $8.76 | · | $0.17 | $0.32 | $0.57 | |
| Revenue / Share | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | |
| Cash Flow / Share | · | · | · | $-0.08 | · | · | · | $-0.43 | · | · | · | $-2.12 | · | · | · | $-0.37 | |
| Cash / Share | · | $5.38 | $5.51 | $3.60 | · | $4.05 | $3.34 | $3.79 | · | $5.17 | $7.86 | $10.15 | · | $0.23 | $0.38 | $0.64 | |
| EPS (TTM) | · | $-0.95 | $-1.09 | $-1.09 | · | $3.88 | $4.03 | $1.65 | · | $-6.05 | $-8.49 | $-9.19 | · | $-50.26 | $-47.99 | $-45.24 |
Valuation (TTM)
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | $7.0K | $61.0K | $75.0K | · | $68.0K | $62.0K | $73.0K | |
| Net Income TTM | · | $-42M | $-44M | $-42M | · | $-34M | $-24M | $-21M | · | $-22M | $-22M | $-20M | · | $-20M | $-19M | $-18M | |
| Market Cap | · | $366M | $461M | $368M | · | $332M | $296M | $164M | · | $14M | $8M | $8M | · | $100M | $81M | $163M | |
| P/E | · | -11.2 | -12.4 | -12.9 | · | 3.4 | 3.1 | 5.6 | · | -0.9 | -0.4 | -0.3 | · | -0.1 | -0.1 | -0.1 | |
| P/S | · | · | · | · | · | · | · | · | · | 2043.6 | 137.3 | 102.6 | · | 1469.0 | 1304.3 | 2235.9 | |
| P/B | · | 2.0 | 2.5 | 3.9 | · | 3.4 | 3.9 | 2.6 | · | 1.2 | 0.5 | 0.3 | · | 21.2 | 9.0 | 11.2 | |
| P / Tangible Book | · | 2.0 | 2.5 | 3.9 | · | 3.4 | 3.9 | 2.6 | · | 1.2 | 0.5 | 0.3 | · | 21.2 | 9.0 | 11.2 | |
| P / Cash Flow | · | · | · | -109.9 | · | · | · | -35.9 | · | · | · | -1.7 | · | · | · | -40.4 | |
| Earnings Yield | · | -8.9% | -8.1% | -7.8% | · | 29.8% | 31.9% | 17.9% | · | -115.2% | -262.8% | -304.1% | · | -1407.8% | -1660.5% | -715.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Revenue | · | · | $0 | $75.0K | $73.0K |
| Operating Margin % | · | · | · | -25441.3% | -24457.5% |
| Net Income | $-46M | $-38M | $-22M | $-20M | $-18M |
| Diluted EPS | $-0.98 | $-1.05 | $-1.22 | $-14.12 | $-37.88 |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 34.0 | 54.7 | 10.5 | 0.9 | 1.9 |
| Quick Ratio | 33.7 | 54.2 | 10.3 | 0.6 | 1.6 |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-17M | $-24M | $-20M | $-18M | $-16M |
Institutional owners (13F) 89 filers · $456.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
89
Value held
$456.5M
New positions
11
Exited positions
10
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-15 vs prior Q) | 10 (+1 vs prior Q) | 35 (+1 vs prior Q) | 21 (+8 vs prior Q) | -1.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $154,516,936 | 11,548,351 | 33.85% | Shares |
| FRANKLIN RESOURCES INC | $32,284,447 | 2,412,888 | 7.07% | Shares |
| JANUS HENDERSON GROUP PLC | $30,719,738 | 2,876,380 | 6.73% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $28,374,591 | 2,120,672 | 6.22% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $24,753,000 | 1,850,000 | 5.42% | Shares |
| Nantahala Capital Management, LLC | $19,914,404 | 1,488,371 | 4.36% | Shares |
| BlackRock, Inc. | $18,827,507 | 1,407,138 | 4.12% | Shares |
| VANGUARD GROUP INC | $15,823,990 | 1,174,758 | 3.47% | Shares |
| Simplify Asset Management Inc. | $13,454,353 | 1,005,557 | 2.95% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,771,652 | 954,533 | 2.80% | Shares |
| INFINITUM ASSET MANAGEMENT, LLC | $12,349,820 | 923,006 | 2.71% | Shares |
| MILLENNIUM MANAGEMENT LLC | $12,326,981 | 921,299 | 2.70% | Shares |
| Alyeska Investment Group, L.P. | $10,035,000 | 750,000 | 2.20% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $9,096,072 | 679,826 | 1.99% | Shares |
| Balyasny Asset Management L.P. | $8,703,730 | 650,503 | 1.91% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $8,186,806 | 611,736 | 1.79% | Shares |
| AMERIPRISE FINANCIAL INC | $5,368,658 | 401,245 | 1.18% | Shares |
| STATE STREET CORP | $5,057,279 | 377,973 | 1.11% | Shares |
| MYDA Advisors LLC | $3,345,000 | 250,000 | 0.73% | Shares |
| Schonfeld Strategic Advisors LLC | $3,149,076 | 235,357 | 0.69% | Shares |
| AWM Investment Company, Inc. | $2,515,132 | 187,977 | 0.55% | Shares |
| NORTHERN TRUST CORP | $2,387,447 | 178,434 | 0.52% | Shares |
| GOLDMAN SACHS GROUP INC | $2,382,188 | 178,041 | 0.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,154,113 | 160,995 | 0.47% | Shares |
| Burkehill Global Management, LP | $2,007,000 | 150,000 | 0.44% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,920,164 | 143,510 | 0.42% | Shares |
| Russell Investments Group, Ltd. | $1,725,617 | 128,970 | 0.38% | Shares |
| UBS Group AG | $1,678,267 | 125,431 | 0.37% | Shares |
| CITADEL ADVISORS LLC | $1,090,015 | 81,466 | 0.24% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $947,986 | 70,851 | 0.21% | Shares |
| Lion Point Capital, LP | $829,560 | 62,000 | 0.18% | Shares |
| Bank of New York Mellon Corp | $803,616 | 60,061 | 0.18% | Shares |
| Atom Investors LP | $650,148 | 48,591 | 0.14% | Shares |
| CANTOR FITZGERALD, L. P. | $624,297 | 46,659 | 0.14% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $603,518 | 45,106 | 0.13% | Shares |
| ADAR1 Capital Management, LLC | $535,200 | 40,000 | 0.12% | Shares |
| Nuveen, LLC | $379,176 | 28,339 | 0.08% | Shares |
| RHUMBLINE ADVISERS | $351,108 | 26,242 | 0.08% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $300,796 | 22,481 | 0.07% | Shares |
| DEUTSCHE BANK AG\ | $278,571 | 20,820 | 0.06% | Shares |
| MORGAN STANLEY | $261,927 | 19,576 | 0.06% | Shares |
| WELLS FARGO & COMPANY/MN | $240,064 | 17,942 | 0.05% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $230,136 | 17,200 | 0.05% | Shares |
| MARTINGALE ASSET MANAGEMENT L P | $216,087 | 16,150 | 0.05% | Shares |
| BANK OF AMERICA CORP /DE/ | $213,692 | 15,971 | 0.05% | Shares |
| MetLife Investment Management, LLC | $206,373 | 15,424 | 0.05% | Shares |
| Quadrature Capital Ltd | $205,664 | 15,371 | 0.05% | Shares |
| EntryPoint Capital, LLC | $201,342 | 15,048 | 0.04% | Shares |
| Longaeva Partners L.P. | $199,014 | 14,874 | 0.04% | Shares |
| Persistent Asset Partners Ltd | $167,156 | 12,493 | 0.04% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd., Aaron Cowen ×2 filings | Nov. 10, 2025 | 44.10% | Amendment | · | SEC |
| Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd., Suvretta Capital Management, LLC, Aaron Cowen ×3 filings | Nov. 18, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 3 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jerel A. Banks | Chief Executive Officer | Nov. 18, 2025 A | · | 0 | 0 | $0 |
| Megan Boston | Chief Financial Officer | Nov. 18, 2025 A | 25,907 | 0 | 0 | $0 |
| Sophie Mukadam | Chief Operating Officer | Nov. 18, 2025 A | · | 0 | 0 | $0 |
| Kevin J Buchi | Director | June 29, 2026 G | 52,097 | 0 | 0 | $0 |
| David Matthew Friedman | Director | May 26, 2026 A | · | 0 | 0 | $0 |
| Sharon Mates | Director | Jan. 22, 2026 A | · | 0 | 0 | $0 |
| Kishan Mehta | Director | Dec. 1, 2025 A | · | 0 | 0 | $0 |
| Peter Francis | Director | Dec. 1, 2025 A | · | 0 | 0 | $0 |
| Edward F Smith | Director | Dec. 1, 2025 A | · | 0 | 0 | $0 |
| Steven Michael Oliveira | 10% owner | Dec. 9, 2021 P | 1,000,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 12 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.43% | 2,641 SH | Sept. 11, 2026 | Daily |
| IWC · iShares Trust | 0.06% | 72,301 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 17,460 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 122,243 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 523,707 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 10,191 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.00% | 11,699 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 281,899 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 649,542 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,497 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,310 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 187,188 SH | Sept. 11, 2026 | Daily |
BNTC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$24.50
+172.8%
5 38.5%
Strong Buy
7 53.8%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-03Mean target $24.33 +171.0%
← Below all targets
Current price $8.98
Low$17.00
Mean$24.33
High$32.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| SRZN | · | · | · | · | · | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| SCTX | · | · | · | · | · | · |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-K filed Sep 14, 2026